{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:16:23Z","timestamp":1783430183529,"version":"3.54.6"},"reference-count":38,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"publisher","award":["25K13533"],"award-info":[{"award-number":["25K13533"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epidemiologia"],"abstract":"<jats:p>Mumps remains a public health challenge worldwide despite being a vaccine-preventable disease. This review outlines the historical development and contrasting mumps vaccination policies in the United States and Japan and their epidemiological consequences. In the United States, where the two-dose measles, mumps, and rubella (MMR) vaccine is routinely administered, the incidence of mumps has markedly decreased. Recently, however, sporadic outbreaks have emerged, driven by breakthrough infections among vaccinated individuals. These resurgences are driven largely by waning immunity, coupled with antigenic divergence between the vaccine strain and circulating wild-type viruses. In contrast, Japan vaccination the MMR vaccine was licensed in 2026 after being suspended in 1993 owing to concerns over aseptic meningitis as an adverse event following immunization but mumps vaccination remains voluntary. This has resulted in low vaccination coverage, a lack of herd immunity, and recurrent epidemics. This review also highlights the disease-modifying effect of mumps vaccination, including a reduced risk of complications such as meningitis and orchitis, even in cases of breakthrough infection. In Japan, irreversible sensorineural hearing loss (mumps deafness), continues to occur even following subclinical infection. To prevent these complications, continuous molecular surveillance, improved vaccine safety, and reintroduction of routine two-dose mumps vaccination in Japan are essential.<\/jats:p>","DOI":"10.3390\/epidemiologia7040095","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:53:46Z","timestamp":1783418026000},"page":"95","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mumps Vaccination Policies and Epidemiological Consequences: A Comparative Review of the United States and Japan"],"prefix":"10.3390","volume":"7","author":[{"given":"Naruhito","family":"Otani","sequence":"first","affiliation":[{"name":"Department of Genetics, Hyogo Medical University, Nishinomiya 663-8501, Japan"},{"name":"Department of Public Health, Hyogo Medical University, Nishinomiya 663-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ohmuraya","sequence":"additional","affiliation":[{"name":"Department of Genetics, Hyogo Medical University, Nishinomiya 663-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiomi","family":"Okuno","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Hyogo Medical University, Nishinomiya 663-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"ref_1","unstructured":"National Institute of Infectious Diseases (NIID) (2016). Mumps (infectious parotitis) in Japan, as of September 2016. Infect. Agents Surveill. Rep. (IASR), 37, 185\u2013186."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.15585\/mmwr.mm6701a7","article-title":"Recommendation of the Advisory Committee on Immunization Practices (ACIP) for use of a third dose of mumps virus-containing vaccine in persons at increased risk for mumps during an outbreak","volume":"67","author":"Marin","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1056\/NEJMoa0706589","article-title":"Recent resurgence of mumps in the United States","volume":"358","author":"Dayan","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa1703309","article-title":"Effectiveness of a third dose of MMR vaccine for mumps outbreak control","volume":"377","author":"Cardemil","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_5","unstructured":"National Institute of Infectious Diseases (NIID) (2003). Mumps (epidemic parotitis) 1993\u20132002. Infect. Agents Surveill. Rep. (IASR), 24, 103\u2013104."},{"key":"ref_6","first-page":"137","article-title":"Live anti-mumps vaccine. I. Results of tests of the immunogenic properties of live vaccine when administered intradermally to susceptible children","volume":"2","author":"Smorodintsev","year":"1958","journal-title":"Acta Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0092-1157(89)90031-0","article-title":"Mumps vaccine L-Zagreb, prepared in chick fibroblasts. I. Production and field trials","volume":"17","author":"Beck","year":"1989","journal-title":"J. Biol. Stand."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3181\/00379727-123-31599","article-title":"Live attenuated mumps virus vaccine. 1. Vaccine development","volume":"123","author":"Buynak","year":"1966","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJM196702022760501","article-title":"Live attenuated mumps-virus vaccine. 3. Clinical and serologic aspects in a field evaluation","volume":"276","author":"Weibel","year":"1967","journal-title":"N. Engl. J. Med."},{"key":"ref_10","first-page":"127","article-title":"Studies on live attenuated mumps virus vaccine. II. Biological characteristics of the strains adapted to the amniotic and chorioallantoic cavity of developing chick embryos","volume":"13","author":"Yamanishi","year":"1970","journal-title":"Biken J."},{"key":"ref_11","first-page":"43","article-title":"Studies on the development of a live attenuated mumps virus vaccine. I. Attenuation of the Hoshino \u201cwild\u201d strain of mumps virus","volume":"49","author":"Sasaki","year":"1976","journal-title":"Kitasato Arch. Exp. Med."},{"key":"ref_12","first-page":"323","article-title":"Development of an attenuated mumps virus Torii strain (Takeda). I. Development of the mumps vaccine strain (Torii) and analysis of its biological characteristics","volume":"9","author":"Hoshino","year":"1981","journal-title":"Rinsho Uirusu (Clin. Virol.)"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1542\/peds.51.3.467","article-title":"Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines","volume":"51","author":"Weibel","year":"1973","journal-title":"Pediatrics"},{"key":"ref_14","unstructured":"Centers for Disease Control and Prevention (1989). Measles prevention. MMWR Morb. Mortal. Wkly. Rep., 38, 1\u201318."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2307\/4593236","article-title":"Surveillance of mumps in the United States as background for use of vaccine","volume":"83","author":"Witte","year":"1968","journal-title":"Public Health Rep."},{"key":"ref_16","unstructured":"Centers for Disease Control and Prevention (CDC) (1985). Current trends: Mumps\u2014United States, 1984\u20131985. MMWR Morb. Mortal. Wkly. Rep., 34, 547\u2013549."},{"key":"ref_17","unstructured":"Centers for Disease Control and Prevention (CDC) (1995). Mumps surveillance\u2014United States, 1988\u20131993. MMWR CDC Surveill. Summ., 44, 1\u201313."},{"key":"ref_18","unstructured":"Centers for Disease Control and Prevention (CDC) (2026, April 27). Mumps Cases and Outbreaks, Available online: https:\/\/www.cdc.gov\/mumps\/outbreaks\/index.html."},{"key":"ref_19","unstructured":"National Institute of Infectious Diseases (NIID) (2026, May 06). Annual List of Infectious Disease Outbreak Trends\u20132023. Infectious Disease Weekly Report (IDWR), Available online: https:\/\/id-info.jihs.go.jp\/surveillance\/idwr\/idwr\/2023\/year-data\/teiten\/index.html."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention (CDC) (2016). Vaccination Coverage Among Children in Kindergarten\u2014United States, 2015\u201316 School Year. MMWR Morb. Mortal. Wkly. Rep., 65, 1057\u20131064.","DOI":"10.15585\/mmwr.mm6539a3"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention (CDC) (2016). National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 years\u2014United States, 2015. MMWR Morb. Mortal. Wkly. Rep., 65, 850\u2013858.","DOI":"10.15585\/mmwr.mm6533a4"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention (CDC) (2024). Coverage with selected vaccines and exemption rates among children in kindergarten\u2014United States, 2023\u201324 school year. MMWR Morb. Mortal. Wkly. Rep., 73, 925\u2013932.","DOI":"10.15585\/mmwr.mm7341a3"},{"key":"ref_23","unstructured":"National Institute of Infectious Diseases (NIID) (2026, July 02). Mumps Immunization Status in Japan, 2024. National Epidemiological Surveillance of Vaccine-Preventable Diseases (NESVPD), Available online: https:\/\/id-info.jihs.go.jp\/surveillance\/nesvpd\/graph\/2024\/mumps\/immunization\/index.html."},{"key":"ref_24","unstructured":"National Institute of Infectious Diseases (NIID), Japan (2026, May 06). The Situation of Mumps in Japan from 1983 to 2024, as Seen from Infectious Disease Surveillance Data. Infectious Disease Weekly Report (IDWR), Available online: https:\/\/id-info.jihs.go.jp\/surveillance\/idwr\/article\/mumps\/010\/index.html."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.idnow.2021.05.004","article-title":"Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?","volume":"51","author":"Cohen","year":"2021","journal-title":"Infect. Dis. Now"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Swain, A.C., Borghans, J.A.M., and de Boer, R.J. (2022). Effect of cellular aging on memory T-cell homeostasis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.947242"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.20344\/amp.5756","article-title":"Mumps Outbreak among Highly Vaccinated Teenagers and Children in the Central Region of Portugal, 2012\u20132013","volume":"28","author":"Cordeiro","year":"2015","journal-title":"Acta M\u00e9dica Port."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Latner, D.R., and Hickman, C.J. (2015). Remembering mumps. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004791"},{"key":"ref_29","first-page":"2368","article-title":"Mumps-specific cross-neutralization by MMR vaccine-induced antibodies is low","volume":"32","author":"Gouma","year":"2014","journal-title":"Vaccine"},{"key":"ref_30","unstructured":"Centers for Disease Control and Prevention (CDC) (2026, April 27). Infection Control in Healthcare Personnel: Epidemiology and Control of Selected Infections Transmitted Among Healthcare Personnel and Patients: Cytomegalovirus, Diphtheria, Group A Streptococcus, Measles, Meningococcal Disease, Mumps, Parvovirus B19, Pertussis, Rabies, Rubella, Varicella-Zoster Virus, and Special Populations: Pregnant Healthcare Personnel. Updated December 10, 2025. Pages 31\u201332, Available online: https:\/\/www.cdc.gov\/infection-control\/media\/pdfs\/HCP-GL-Update-Selected-Infections-2025-12-508.pdf."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/cid\/ciy137","article-title":"Non-mumps viral parotitis during the 2014\u20132015 influenza season in the United States","volume":"67","author":"Elbadawi","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1128\/CVI.00660-12","article-title":"Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York City in 2009","volume":"20","author":"Rota","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0923-2516(96)89653-1","article-title":"Rapid detection and typing of circulating mumps virus by reverse transcription\/polymerase chain reaction","volume":"147","author":"Cusi","year":"1996","journal-title":"Res. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3201\/eid1704.101461","article-title":"Mumps complications and effects of mumps vaccination, England and Wales, 2002\u20132006","volume":"17","author":"Yung","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMoa1202865","article-title":"Mumps outbreaks in orthodox Jewish communities in the United States","volume":"367","author":"Barskey","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3201\/eid2004.131681","article-title":"Epidemic of mumps among vaccinated persons, The Netherlands, 2009\u20132012","volume":"20","author":"Sane","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3950\/jibiinkoka.121.1173","article-title":"Nationwide survey of hearing loss caused by mumps during 2015-2016 in Japan","volume":"121","author":"Morimoto","year":"2018","journal-title":"Nippon Jibiinkoka Gakkai Kaiho"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Otani, N., Shima, M., Ueda, T., Nakajima, K., Takesue, Y., Yamamoto, T., and Okuno, T. (2023). Changes in the epidemiology of rubella: The influence of vaccine-introducing methods and COVID-19. Vaccines, 11.","DOI":"10.3390\/vaccines11081358"}],"container-title":["Epidemiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2673-3986\/7\/4\/95\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:42:26Z","timestamp":1783428146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2673-3986\/7\/4\/95"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["epidemiologia7040095"],"URL":"https:\/\/doi.org\/10.3390\/epidemiologia7040095","relation":{},"ISSN":["2673-3986"],"issn-type":[{"value":"2673-3986","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]}}}